(600976)"Jianmin Pharmaceutical Group Co., Ltd."Announcement on Convening the Q3 2026 Performance Briefing
Filed with SSE · Stock code 600976 · · 2 pages · Chinese
Summary by 6ix AI
Investors can participate online through the Shanghai Stock Exchange's platform and submit questions prior to the event. The company aims to address common investor concerns regarding its financial results during this session.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Jianmin Pharmaceutical Group Co Ltd. on 6ix
Story so far
Earlier from Jianmin Pharmaceutical
- Announcement on Approval for Marketing of Crisaborole Ointment
- Semi-annual Report for 2026
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Inclusion of the Company's Products in the "National Essential Medicines List"
- Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Hubei Jurisdiction
Later from Jianmin Pharmaceutical
All Jianmin Pharmaceutical news releasesFollow Jianmin Pharmaceutical into a list and get an email when it puts out news.
Follow Jianmin Pharmaceutical